- Home
- DHAI vs TRIB Comparison
DHAI vs TRIB Comparison
Compare DHAI & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHAI
- TRIB
- Stock Information
- Founded
- DHAI 2007
- TRIB 1992
- Country
- DHAI United States
- TRIB Ireland
- Employees
- DHAI N/A
- TRIB N/A
- Industry
- DHAI
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DHAI
- TRIB Health Care
- Exchange
- DHAI NYSE
- TRIB Nasdaq
- Market Cap
- DHAI 11.6M
- TRIB 14.0M
- IPO Year
- DHAI N/A
- TRIB N/A
- Fundamental
- Price
- DHAI $0.27
- TRIB $0.67
- Analyst Decision
- DHAI
- TRIB
- Analyst Count
- DHAI 0
- TRIB 0
- Target Price
- DHAI N/A
- TRIB N/A
- AVG Volume (30 Days)
- DHAI 2.6M
- TRIB 216.7K
- Earning Date
- DHAI 08-18-2025
- TRIB 08-13-2025
- Dividend Yield
- DHAI N/A
- TRIB N/A
- EPS Growth
- DHAI N/A
- TRIB N/A
- EPS
- DHAI N/A
- TRIB N/A
- Revenue
- DHAI $69,573,000.00
- TRIB $61,555,000.00
- Revenue This Year
- DHAI N/A
- TRIB $13.51
- Revenue Next Year
- DHAI N/A
- TRIB $13.14
- P/E Ratio
- DHAI N/A
- TRIB N/A
- Revenue Growth
- DHAI 5.40
- TRIB 8.31
- 52 Week Low
- DHAI $0.12
- TRIB $0.48
- 52 Week High
- DHAI $3.25
- TRIB $3.39
- Technical
- Relative Strength Index (RSI)
- DHAI 53.70
- TRIB 43.87
- Support Level
- DHAI $0.24
- TRIB $0.65
- Resistance Level
- DHAI $0.31
- TRIB $0.79
- Average True Range (ATR)
- DHAI 0.03
- TRIB 0.06
- MACD
- DHAI 0.00
- TRIB -0.01
- Stochastic Oscillator
- DHAI 50.63
- TRIB 13.67
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.